List of medicines in Japan for treatment:
Alternative to Nesina in Japan
The best equivalent of Nesina in Japan called Nesina. Analogue has exactly the same ingredients, pharmacological group, treatment option
You can buy Nesina (alternative to Nesina) in pharmacies of Japan.
Attention! Always consult to a doctor or pharmacist before using pills or medicines.
Where to buy
China
Ingredients
Alogliptin
Treatment option
Pharmacological group
equal
equal
equal

Japan
Ingredients equal
Alogliptin
Treatment option equal
Pharmacological group equal
Where to buy Nesina or alternative in Japan
To buy Nesina or its alternatives in Japan, we recommend to contact your nearest pharmacy. Call the pharmacy using the number on the map, to find out if Nesina is in stock. Remember to ask the pharmacist about the price of the medicine and the requirement to provide a prescription, many medicines in Japan are sold strictly according to the doctor's prescription. Show pharmacy near me.
Show pharmacy near me
Pillintrip.com is not a pharmacy!
Advertisements
Advertisements
Other analogues
| Name | Ingredients | Treatment option | Pharmacological group | ||
| Nesina | 100% | ||||
| Januvia | 80% | ||||
| Hoechst Rastinon | 60% | ||||
| Trazenta | 60% | ||||
| 50% | |||||
| 50% | |||||
| Acarbose Pfizer | 50% | ||||
| Actos | 50% | ||||
| Amaryl | 50% | ||||
| Apidra (INSULIN GLULISINE) | 50% | ||||
| Bydureon | 50% | ||||
| BYETTA | 50% | ||||
| Euglucon | 50% | ||||
| Glimepiride BMD | 50% | ||||
| Glucobay | 50% | ||||
| Humalog | 50% | ||||
| Lantus (Insulin Glargine) | 50% | ||||
| Levemir | 50% | ||||
| Lyxumia | 50% | ||||
| Medet | 50% | ||||
| Metgluco | 50% | ||||
| NovoRapid | 50% | ||||
| Onglyza | 50% | ||||
| Surepost | 50% | ||||
| Tresiba | 50% | ||||
| Apidra | 50% | ||||
| Equa | 50% | ||||
| Gliclazide Sawai | 50% | ||||
| Glimicron | 50% | ||||
| Humalog Mix 50 (Insulin Lispro) | 50% | ||||
| Lantus | 50% | ||||
| NovoRapid 30 Mix (Insulin Aspart) | 50% | ||||
| NovoRapid 50 Mix (Insulin Aspart) | 50% |
Advertisements
Advertisements
Advertisements
Advertisements




